Universal Biosensors, Inc. (UBI.AX)
AUD 0.13
(0.0%)
AUD 0.13
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 6.63 Million AUD | 46.58% |
| 2022 | 4.52 Million AUD | -21.68% |
| 2021 | 5.77 Million AUD | 80.41% |
| 2020 | 3.2 Million AUD | -53.57% |
| 2019 | 6.89 Million AUD | -90.07% |
| 2018 | 69.45 Million AUD | 175.72% |
| 2017 | 25.19 Million AUD | 33.78% |
| 2016 | 18.83 Million AUD | 12.26% |
| 2015 | 16.77 Million AUD | 76.03% |
| 2014 | 9.52 Million AUD | -36.85% |
| 2013 | 15.08 Million AUD | -49.1% |
| 2012 | 29.64 Million AUD | 101.31% |
| 2011 | 14.72 Million AUD | -18.99% |
| 2010 | 18.18 Million AUD | -17.52% |
| 2009 | 22.04 Million AUD | 383.68% |
| 2008 | 4.55 Million AUD | 252.3% |
| 2007 | 1.29 Million AUD | -51.26% |
| 2006 | 2.65 Million AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 1.46 Million AUD | -30.63% |
| 2024 Q2 | 1.62 Million AUD | 10.62% |
| 2024 Q3 | 1.86 Million AUD | 14.84% |
| 2023 FY | 6.63 Million AUD | 46.58% |
| 2023 Q2 | 1.3 Million AUD | 0.64% |
| 2023 Q1 | 1.29 Million AUD | 70.19% |
| 2023 Q3 | 1.91 Million AUD | 46.9% |
| 2023 Q4 | 2.11 Million AUD | 10.61% |
| 2022 Q3 | 679.97 Thousand AUD | -50.02% |
| 2022 Q4 | 761.19 Thousand AUD | 11.94% |
| 2022 FY | 4.52 Million AUD | -21.68% |
| 2022 Q1 | 1.72 Million AUD | 40.45% |
| 2022 Q2 | 1.36 Million AUD | -21.04% |
| 2021 Q1 | 1.54 Million AUD | -10.29% |
| 2021 Q3 | 1.15 Million AUD | -37.09% |
| 2021 Q4 | 1.22 Million AUD | 5.86% |
| 2021 Q2 | 1.84 Million AUD | 18.89% |
| 2021 FY | 5.77 Million AUD | 80.41% |
| 2020 Q2 | 546.61 Thousand AUD | 5.76% |
| 2020 Q3 | 411.88 Thousand AUD | -24.65% |
| 2020 FY | 3.2 Million AUD | -53.57% |
| 2020 Q1 | 516.83 Thousand AUD | -65.7% |
| 2020 Q4 | 1.72 Million AUD | 319.36% |
| 2019 Q3 | 1.41 Million AUD | -33.03% |
| 2019 FY | 6.89 Million AUD | -90.07% |
| 2019 Q4 | 1.5 Million AUD | 6.62% |
| 2019 Q2 | 2.11 Million AUD | 13.01% |
| 2019 Q1 | 1.86 Million AUD | -78.62% |
| 2018 FY | 69.45 Million AUD | 175.72% |
| 2018 Q4 | 8.73 Million AUD | -81.51% |
| 2018 Q3 | 47.23 Million AUD | 713.54% |
| 2018 Q2 | 5.8 Million AUD | -24.44% |
| 2018 Q1 | 7.68 Million AUD | 70.07% |
| 2017 Q4 | 4.51 Million AUD | -28.8% |
| 2017 FY | 25.19 Million AUD | 33.78% |
| 2017 Q1 | 7.93 Million AUD | 57.26% |
| 2017 Q2 | 6.39 Million AUD | -19.41% |
| 2017 Q3 | 6.34 Million AUD | -0.76% |
| 2016 Q1 | 5.09 Million AUD | 53.69% |
| 2016 FY | 18.83 Million AUD | 12.26% |
| 2016 Q3 | 3.28 Million AUD | -39.14% |
| 2016 Q2 | 5.4 Million AUD | 5.97% |
| 2016 Q4 | 5.04 Million AUD | 53.46% |
| 2015 Q2 | 4.35 Million AUD | 39.9% |
| 2015 Q4 | 3.31 Million AUD | -44.7% |
| 2015 Q3 | 5.99 Million AUD | 37.85% |
| 2015 Q1 | 3.1 Million AUD | -32.06% |
| 2015 FY | 16.77 Million AUD | 76.03% |
| 2014 Q1 | 1.35 Million AUD | -54.88% |
| 2014 FY | 9.52 Million AUD | -36.85% |
| 2014 Q4 | 4.57 Million AUD | 119.36% |
| 2014 Q3 | 2.08 Million AUD | 37.82% |
| 2014 Q2 | 1.51 Million AUD | 11.98% |
| 2013 Q2 | 4.77 Million AUD | -0.8% |
| 2013 Q1 | 4.8 Million AUD | -23.28% |
| 2013 FY | 15.08 Million AUD | -49.1% |
| 2013 Q4 | 2.99 Million AUD | 19.22% |
| 2013 Q3 | 2.51 Million AUD | -47.31% |
| 2012 Q3 | 8.65 Million AUD | 4.1% |
| 2012 FY | 29.64 Million AUD | 101.31% |
| 2012 Q2 | 8.31 Million AUD | 29.93% |
| 2012 Q1 | 6.4 Million AUD | 0.0% |
| 2012 Q4 | 6.26 Million AUD | -27.6% |
| 2011 Q1 | 3.56 Million AUD | 0.0% |
| 2011 FY | 14.72 Million AUD | -18.99% |
| 2011 Q3 | 2.47 Million AUD | -9.89% |
| 2011 Q2 | 2.74 Million AUD | -23.04% |
| 2010 Q1 | 3.41 Million AUD | 0.0% |
| 2010 Q3 | 4.98 Million AUD | 80.51% |
| 2010 Q2 | 2.76 Million AUD | -19.15% |
| 2010 FY | 18.18 Million AUD | -17.52% |
| 2009 Q3 | 1.13 Million AUD | 70.6% |
| 2009 FY | 22.04 Million AUD | 383.68% |
| 2009 Q2 | 662.43 Thousand AUD | -64.3% |
| 2009 Q1 | 1.85 Million AUD | 0.0% |
| 2008 FY | 4.55 Million AUD | 252.3% |
| 2007 FY | 1.29 Million AUD | -51.26% |
| 2006 FY | 2.65 Million AUD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| 4DMedical Limited | 3.75 Million AUD | -76.675% |
| Adherium Limited | 840.98 Thousand AUD | -688.702% |
| Aroa Biosurgery Limited | 63.35 Million AUD | 89.531% |
| Atomo Diagnostics Limited | 4.08 Million AUD | -62.31% |
| Anteris Technologies Ltd | 4.11 Million AUD | -61.34% |
| Control Bionics Limited | 5.12 Million AUD | -29.373% |
| CardieX Limited | 10.9 Million AUD | 39.18% |
| Compumedics Limited | 49.71 Million AUD | 86.659% |
| Cochlear Limited | 2.25 Billion AUD | 99.706% |
| CleanSpace Holdings Limited | 15.72 Million AUD | 57.811% |
| Cyclopharm Limited | 27.13 Million AUD | 75.56% |
| EMVision Medical Devices Ltd | 11.21 Million AUD | 40.88% |
| Nova Eye Medical Limited | 23.32 Million AUD | 71.563% |
| HeraMED Limited | 402.89 Thousand AUD | -1546.286% |
| Imricor Medical Systems, Inc. | 615.56 Thousand AUD | -977.515% |
| ImpediMed Limited | 10.31 Million AUD | 35.722% |
| InhaleRx Limited | 1.2 Million AUD | -450.879% |
| LBT Innovations Limited | 1.25 Million AUD | -428.092% |
| Micro-X Limited | 15.22 Million AUD | 56.426% |
| Neurotech International Limited | 1963.00 AUD | -337792.919% |
| OncoSil Medical Limited | 1.56 Million AUD | -323.72% |
| PolyNovo Limited | 103.19 Million AUD | 93.572% |
| Respiri Limited | 456.91 Thousand AUD | -1351.66% |
| SomnoMed Limited | 91.65 Million AUD | 92.763% |
| Uscom Limited | 3.72 Million AUD | -77.975% |
| Visioneering Technologies, Inc. | 8.67 Million AUD | 23.497% |